Home BIOTECH Stocks In News: Pilgrim’s Pride Corporation(NASDAQ:PPC), Pitney Bowes Inc. (NYSE:PBI), MannKind Corporation(NASDAQ:MNKD), Sally Beauty Holdings, Inc. (NYSE:SBH)

Stocks In News: Pilgrim’s Pride Corporation(NASDAQ:PPC), Pitney Bowes Inc. (NYSE:PBI), MannKind Corporation(NASDAQ:MNKD), Sally Beauty Holdings, Inc. (NYSE:SBH)

0
0

Pilgrim’s Pride Corporation(NASDAQ:PPC) shares climbed 4.85% and closed at $10.38. The company on May 2 reported first quarter 2013 earnings results with net sales of $2.0 billion, Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) of $116.9 million and net income of $54.6 million, resulting in earnings per share of $0.21 for the quarter. This compares to $1.9 billion in sales, EBITDA of $101.5 and Net Income of $39.2 million, with earnings per share of $0.18 in the first quarter of 2012.

Pitney Bowes Inc. (NYSE:PBI) shares fell 14.32% and closed at $13.87. The company on April 30 posted a first-quarter net income of $67.51 million, or $0.33 a share, from $158.67 million, or $0.79 a share last year, with income from continuing operations falling year-over-year to $74.16 million, from $145.54 million. Adjusted earnings per share from continuing operations for the first quarter 2013 were $0.42. Analysts expected earnings per share of $0.44 for the quarter. Revenue for the quarter was $1.17 billion, down compared with the prior-year figure of $1.22 billion. Analysts estimated revenues of $1.20 billion for the quarter.

MannKind Corporation(NASDAQ:MNKD) shares increased 1.62% to $8.17. The company has recently implemented BioPharm Systems’ ASCEND, a pre-configured and enhanced version of Oracle’s Siebel Clinical Trial Management System (CTMS), to support its growing biopharmaceutical product pipeline. ASCEND is replacing MannKind’s existing commercial CTMS, which no longer meets the needs of their clinical operations team.

Sally Beauty Holdings, Inc. (NYSE:SBH) shares dropped 9.31% to $27.68. The company, on August 1, announced financial results for the fiscal 2013 third quarter. For the fiscal 2013 third quarter, consolidated net sales were $912.1 million, an increase of 2.8% from the fiscal 2012 third quarter. In the fiscal 2013 third quarter, net earnings were $72.5 million, an increase of 4.3% over fiscal 2012 third quarter GAAP net earnings of $69.5 million. Diluted earnings per share in the fiscal 2013 third quarter were $0.42, growth of 13.5% when compared to GAAP diluted earnings per share of $0.37 in the fiscal 2012 third quarter.